Role	O
for	O
the	O
Epstein-Barr	B-protein
virus	I-protein
nuclear	I-protein
antigen	I-protein
2	I-protein
in	O
viral	B-DNA
promoter	I-DNA
switching	O
during	O
initial	O
stages	O
of	O
infection	O
.	O

During	O
latent	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
infection	O
of	O
human	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
,	O
six	B-protein
viral	I-protein
nuclear	I-protein
antigen	I-protein
(	O
EBNAs	B-protein
)	O
are	O
expressed	O
from	O
long	B-RNA
primary	I-RNA
transcripts	I-RNA
by	O
means	O
of	O
alternative	B-RNA
splicing	I-RNA
and	O
alternative	B-RNA
polyadenylylation	I-RNA
sites	I-RNA
.	O

These	O
transcripts	O
initiate	O
from	O
one	O
of	O
two	O
promoters	B-DNA
,	O
Cp	B-DNA
or	O
Wp	O
,	O
that	O
function	O
in	O
a	O
mutually	O
exclusive	O
fashion	O
.	O

Wp	O
is	O
exclusively	O
utilized	O
during	O
the	O
initial	O
stages	O
of	O
infection	O
of	O
primary	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
,	O
followed	O
by	O
a	O
switch	O
to	O
Cp	B-DNA
usage	O
.	O

These	O
studies	O
have	O
been	O
extended	O
to	O
show	O
that	O
(	O
i	O
)	O
a	O
mutant	O
EBV	O
strain	O
lacking	O
the	O
gene	O
encoding	O
EBNA	B-protein
2	I-protein
fails	O
to	O
switch	O
from	O
Wp	O
to	O
Cp	B-DNA
usage	O
in	O
primary	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
,	O
although	O
the	O
virus	O
contains	O
a	O
functional	O
Cp	B-DNA
;	O
(	O
ii	O
)	O
a	O
region	O
from	O
-429	B-DNA
to	I-DNA
-245	I-DNA
base	I-DNA
pairs	I-DNA
upstream	O
of	O
Cp	B-DNA
is	O
essential	O
for	O
Cp	B-DNA
activity	O
in	O
B	B-cell_type
lymphocytes	I-cell_type
,	O
but	O
only	O
in	O
the	O
context	O
of	O
upstream	B-DNA
and	I-DNA
downstream	I-DNA
sequences	I-DNA
;	O
(	O
iii	O
)	O
this	O
region	O
contains	O
an	O
EBNA	B-DNA
2-dependent	I-DNA
enhancer	I-DNA
;	O
and	O
(	O
iv	O
)	O
DNase	B-protein
I	I-protein
protection	O
employing	O
nuclear	O
extracts	O
from	O
B	B-cell_type
and	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
revealed	O
a	O
B-cell-specific	B-DNA
footprint	I-DNA
in	O
the	O
region	O
of	O
the	O
EBNA	B-DNA
2-dependent	I-DNA
enhancer	I-DNA
.	O

These	O
results	O
support	O
a	O
model	O
for	O
viral	B-DNA
promoter	I-DNA
switching	O
during	O
the	O
initial	O
stages	O
of	O
infection	O
in	O
which	O
Wp	O
activity	O
leads	O
to	O
the	O
expression	O
of	O
EBNA	B-protein
2	I-protein
,	O
followed	O
by	O
activation	O
of	O
Cp	B-DNA
through	O
the	O
EBNA	B-DNA
2-dependent	I-DNA
enhancer	I-DNA
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

88	NULL
,	NULL
pp	NULL
.	NULL

3942-3946	NULL
,	NULL
May	NULL
1991	NULL
Biochemistry	NULL
Role	NULL
for	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
in	NULL
viral	NULL
promoter	NULL
switching	NULL
during	NULL
initial	NULL
stages	NULL
of	NULL
infection	NULL
(	NULL
infection	NULL
of	NULL
primary	NULL
B	NULL
lymphocytes/Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2-dependent	NULL
enhancer/S1	NULL
nuclease	NULL
protection/in	NULL
vitro	NULL
transcription/DNase	NULL
I	NULL
footprinting	NULL
)	NULL
MaAxIMILIAN	NULL
WoOISETSCHLAEGER	NULL
,	NULL
XIAN	NULL
W.	NULL
JIN	NULL
,	NULL
CHANDRI	NULL
N.	NULL
YANDAvA	NULL
,	NULL
Lisa	NULL
A.	NULL
FURMANSKI	NULL
,	NULL
JACK	NULL
L.	NULL
STROMINGER	NULL
,	NULL
AND	NULL
SaAmuEL	NULL
H.	NULL
Speck	NULL
Division	NULL
of	NULL
Tumor	NULL
Virology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
44	NULL
Binney	NULL
Street	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
Contributed	NULL
by	NULL
Jack	NULL
L.	NULL
Strominger	NULL
,	NULL
January	NULL
2	NULL
,	NULL
1991	NULL
ABSTRACT	NULL
During	NULL
latent	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
infection	NULL
of	NULL
human	NULL
B	NULL
lymphocytes	NULL
,	NULL
six	NULL
viral	NULL
nuclear	NULL
antigens	NULL
(	NULL
EBNAs	NULL
)	NULL
are	NULL
expressed	NULL
from	NULL
long	NULL
primary	NULL
transcripts	NULL
by	NULL
means	NULL
of	NULL
alternative	NULL
splicing	NULL
and	NULL
alternative	NULL
polyadenylylation	NULL
sites	NULL
.	NULL

These	NULL
transcripts	NULL
initiate	NULL
from	NULL
one	NULL
of	NULL
two	NULL
promoters	NULL
,	NULL
Cp	NULL
or	NULL
Wp	NULL
,	NULL
that	NULL
function	NULL
in	NULL
a	NULL
mutually	NULL
exclusive	NULL
fashion	NULL
.	NULL

Wp	NULL
is	NULL
exclusively	NULL
utilized	NULL
during	NULL
the	NULL
initial	NULL
stages	NULL
of	NULL
infection	NULL
of	NULL
primary	NULL
B	NULL
lymphocytes	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
switch	NULL
to	NULL
Cp	NULL
usage	NULL
.	NULL

These	NULL
studies	NULL
have	NULL
been	NULL
extended	NULL
to	NULL
show	NULL
that	NULL
(	NULL
?	NULL
)	NULL

a	NULL
mutant	NULL
EBV	NULL
strain	NULL
lacking	NULL
the	NULL
gene	NULL
encoding	NULL
EBNA	NULL
2	NULL
fails	NULL
to	NULL
switch	NULL
from	NULL
Wp	NULL
to	NULL
Cp	NULL
usage	NULL
in	NULL
primary	NULL
B	NULL
lymphocytes	NULL
,	NULL
although	NULL
the	NULL
virus	NULL
contains	NULL
a	NULL
functional	NULL
Cp	NULL
;	NULL
(	NULL
#	NULL
)	NULL
a	NULL
region	NULL
from	NULL
-429	NULL
to	NULL
-245	NULL
base	NULL
pairs	NULL
upstream	NULL
of	NULL
Cp	NULL
is	NULL
essential	NULL
for	NULL
Cp	NULL
activity	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
but	NULL
only	NULL
in	NULL
the	NULL
context	NULL
of	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
;	NULL
(	NULL
i	NULL
?	NULL
)	NULL

this	NULL
region	NULL
contains	NULL
an	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
;	NULL
and	NULL
(	NULL
iv	NULL
)	NULL
DNase	NULL
I	NULL
protection	NULL
employing	NULL
nuclear	NULL
extracts	NULL
from	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
revealed	NULL
a	NULL
B-cell-specific	NULL
footprint	NULL
in	NULL
the	NULL
region	NULL
of	NULL
the	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
.	NULL

These	NULL
results	NULL
support	NULL
a	NULL
model	NULL
for	NULL
viral	NULL
promoter	NULL
switching	NULL
during	NULL
the	NULL
initial	NULL
stages	NULL
of	NULL
infection	NULL
in	NULL
which	NULL
Wp	NULL
activity	NULL
leads	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
EBNA	NULL
2	NULL
,	NULL
followed	NULL
by	NULL
activation	NULL
of	NULL
Cp	NULL
through	NULL
the	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
a	NULL
human	NULL
lymphotopic	NULL
herpes-virus	NULL
that	NULL
predominantly	NULL
establishes	NULL
a	NULL
latent	NULL
infection	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
with	NULL
a	NULL
concomitant	NULL
growth	NULL
transformation	NULL
of	NULL
the	NULL
infected	NULL
cells	NULL
.	NULL

During	NULL
viral	NULL
latency	NULL
,	NULL
six	NULL
EBV	NULL
nuclear	NULL
antigens	NULL
(	NULL
EBNAs	NULL
)	NULL
are	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
,	NULL
as	NULL
well	NULL
as	NULL
three	NULL
viral	NULL
membrane	NULL
antigens	NULL
.	NULL

The	NULL
viral	NULL
genes	NULL
encoding	NULL
these	NULL
antigens	NULL
are	NULL
spread	NULL
over	NULL
nearly	NULL
two-thirds	NULL
of	NULL
the	NULL
172-kilobase	NULL
(	NULL
kb	NULL
)	NULL
viral	NULL
genome	NULL
.	NULL

However	NULL
,	NULL
transcription	NULL
of	NULL
these	NULL
genes	NULL
initiates	NULL
from	NULL
promoters	NULL
that	NULL
are	NULL
clustered	NULL
near	NULL
the	NULL
fused	NULL
terminal	NULL
repeats	NULL
on	NULL
the	NULL
viral	NULL
episome	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
refs	NULL
.	NULL

1-3	NULL
)	NULL
.	NULL

Two	NULL
promoters	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
Cp	NULL
and	NULL
Wp	NULL
)	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
driving	NULL
transcription	NULL
of	NULL
the	NULL
six	NULL
EBNA	NULL
genes	NULL
,	NULL
and	NULL
they	NULL
function	NULL
in	NULL
a	NULL
mutually	NULL
exclusive	NULL
fashion	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Infection	NULL
of	NULL
peripheral	NULL
B	NULL
lymphocytes	NULL
with	NULL
EBV	NULL
leads	NULL
initially	NULL
to	NULL
exclusive	NULL
Wp	NULL
usage	NULL
,	NULL
followed	NULL
by	NULL
up-regulation	NULL
of	NULL
Cp	NULL
(	NULL
5	NULL
)	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
the	NULL
issue	NULL
of	NULL
the	NULL
switch	NULL
to	NULL
Cp	NULL
usage	NULL
is	NULL
addressed	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
,	NULL
Transfections	NULL
,	NULL
and	NULL
Chloramphenicol	NULL
Acetyltrans-ferase	NULL
(	NULL
CAT	NULL
)	NULL
Assays	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

DNA	NULL
transfections	NULL
were	NULL
carried	NULL
out	NULL
either	NULL
by	NULL
using	NULL
Lipofectin	NULL
(	NULL
BRL	NULL
;	NULL
ref	NULL
.	NULL

4	NULL
)	NULL
or	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
DG75	NULL
,	NULL
by	NULL
using	NULL
DEAE-dextran	NULL
as	NULL
described	NULL
(	NULL
6	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

3942	NULL
described	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
EBNA	NULL
2	NULL
expression	NULL
vector	NULL
employed	NULL
in	NULL
the	NULL
cotransfection	NULL
experiments	NULL
,	NULL
pEAAG6	NULL
,	NULL
has	NULL
been	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

SVpCAT	NULL
contains	NULL
an	NULL
enhancerless	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
early	NULL
promoter	NULL
and	NULL
was	NULL
described	NULL
earlier	NULL
(	NULL
9	NULL
)	NULL
.	NULL

EBV	NULL
sequences	NULL
from	NULL
-429	NULL
(	NULL
Avr	NULL
II	NULL
)	NULL
to	NULL
-245	NULL
(	NULL
Sac	NULL
I	NULL
)	NULL
upstream	NULL
of	NULL
Cp	NULL
were	NULL
cloned	NULL
in	NULL
both	NULL
orientations	NULL
upstream	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
(	NULL
[	NULL
-429/-245	NULL
]	NULL
SVpCAT	NULL
and	NULL
[	NULL
-245/-429	NULL
]	NULL
SVp-CAT	NULL
)	NULL
or	NULL
downstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
SVpCAT	NULL
[	NULL
-429/	NULL
-245	NULL
}	NULL
)	NULL
.	NULL

In	NULL
SVpCAT	NULL
[	NULL
-340/-245	NULL
]	NULL
,	NULL
a	NULL
(	NULL
shorter	NULL
)	NULL
95-base-pair	NULL
(	NULL
bp	NULL
)	NULL
Kpn	NULL
I/	NULL
Sac	NULL
1	NULL
fragment	NULL
upstream	NULL
of	NULL
Cp	NULL
was	NULL
cloned	NULL
into	NULL
SVpCAT	NULL
.	NULL

The	NULL
C1ICAT	NULL
plasmid	NULL
series	NULL
has	NULL
been	NULL
described	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
Vitro	NULL
Infection	NULL
of	NULL
Peripheral	NULL
Blood	NULL
Lymphocytes	NULL
,	NULL
RNA	NULL
Preparation	NULL
,	NULL
and	NULL
S1	NULL
Nuclease	NULL
Protection	NULL
.	NULL

Virus	NULL
was	NULL
prepared	NULL
from	NULL
Akata	NULL
cells	NULL
(	NULL
an	NULL
immortalizing	NULL
strain	NULL
of	NULL
EBV	NULL
)	NULL
(	NULL
10	NULL
)	NULL
by	NULL
induction	NULL
with	NULL
anti-IgG	NULL
as	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Virus	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
clone-13	NULL
cell	NULL
line	NULL
(	NULL
an	NULL
EBV-positive	NULL
,	NULL
EBNA	NULL
2-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
)	NULL
after	NULL
induction	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
at	NULL
20	NULL
ng/ml	NULL
for	NULL
10	NULL
days	NULL
.	NULL

Infections	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Auffray	NULL
and	NULL
Rougeon	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Fifty	NULL
micrograms	NULL
of	NULL
RNA	NULL
was	NULL
used	NULL
in	NULL
S1	NULL
nuclease	NULL
protection	NULL
analyses	NULL
,	NULL
employing	NULL
specific	NULL
oligonucleotides	NULL
diagnostic	NULL
for	NULL
Cp	NULL
or	NULL
Wp	NULL
activity	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Cloning	NULL
Cp	NULL
.	NULL

EcoRI/Xho	NULL
I	NULL
restriction	NULL
endonuclease-digested	NULL
genomic	NULL
DNA	NULL
from	NULL
the	NULL
Cp-using	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
JY	NULL
and	NULL
from	NULL
clone-13	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
Uni-ZAP	NULL
XR	NULL
vector	NULL
(	NULL
Stratagene	NULL
)	NULL
,	NULL
and	NULL
positive	NULL
clones	NULL
were	NULL
recovered	NULL
by	NULL
screening	NULL
the	NULL
library	NULL
with	NULL
an	NULL
oriP-containing	NULL
probe	NULL
.	NULL

DNA	NULL
sequencing	NULL
revealed	NULL
a	NULL
new	NULL
Xho	NULL
I	NULL
site	NULL
in	NULL
the	NULL
clone	NULL
from	NULL
clone-13	NULL
at	NULL
position	NULL
13,143	NULL
(	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
B95.8	NULL
map	NULL
)	NULL
,	NULL
just	NULL
upstream	NULL
of	NULL
the	NULL
BamHI	NULL
C/W	NULL
junction	NULL
at	NULL
13,215	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
5.8-kb	NULL
insert	NULL
containing	NULL
only	NULL
BamHI	NULL
C	NULL
sequences	NULL
.	NULL

The	NULL
Xho	NULL
I	NULL
site	NULL
in	NULL
the	NULL
clone-13	NULL
clone	NULL
was	NULL
converted	NULL
to	NULL
a	NULL
BamHI	NULL
site	NULL
,	NULL
and	NULL
the	NULL
entire	NULL
insert	NULL
was	NULL
used	NULL
to	NULL
replace	NULL
the	NULL
equivalent	NULL
EcoRI/BamHI	NULL
fragment	NULL
in	NULL
CWWiglobin	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
which	NULL
resulted	NULL
in	NULL
the	NULL
deletion	NULL
of	NULL
72	NULL
bp	NULL
from	NULL
the	NULL
BamHI	NULL
C	NULL
fragment	NULL
.	NULL

Preparation	NULL
of	NULL
Extracts	NULL
,	NULL
in	NULL
Vitro	NULL
Transcription	NULL
,	NULL
and	NULL
DNase	NULL
I	NULL
Footprinting	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
12	NULL
)	NULL
with	NULL
slight	NULL
modifications	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
omitting	NULL
the	NULL
crude	NULL
nuclei	NULL
preparation	NULL
step	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
and	NULL
in	NULL
vitro	NULL
transcription	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
(	NULL
11	NULL
,	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

RESULTS	NULL
An	NULL
EBNA	NULL
2	NULL
Mutant	NULL
EBV	NULL
Strain	NULL
Fails	NULL
to	NULL
Switch	NULL
from	NULL
Wp	NULL
to	NULL
Cp	NULL
Usage	NULL
in	NULL
Primary	NULL
B	NULL
Lymphocytes	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
kinetics	NULL
of	NULL
the	NULL
switch	NULL
from	NULL
Wp	NULL
to	NULL
Cp	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
EBNAs	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
viral	NULL
antigens	NULL
are	NULL
either	NULL
directly	NULL
or	NULL
indirectly	NULL
involved	NULL
in	NULL
promoter	NULL
switching	NULL
(	NULL
5	NULL
,	NULL
15	NULL
)	NULL
.	NULL

EBNA	NULL
2	NULL
and	NULL
EBNA	NULL
4	NULL
appear	NULL
to	NULL
be	NULL
the	NULL
first	NULL
viral	NULL
Abbreviations	NULL
:	NULL
EBV	NULL
,	NULL
Epstein-Barr	NULL
virus	NULL
;	NULL
EBNA	NULL
,	NULL
EBV	NULL
nuclear	NULL
antigen	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
SV40	NULL
,	NULL
simian	NULL
virus	NULL
40	NULL
.	NULL

Biochemistry	NULL
:	NULL
Woisetschlaeger	NULL
et	NULL
al	NULL
.	NULL

antigens	NULL
expressed	NULL
upon	NULL
infection	NULL
of	NULL
primary	NULL
B	NULL
lymphocytes	NULL
(	NULL
15	NULL
)	NULL
.	NULL

To	NULL
begin	NULL
to	NULL
address	NULL
their	NULL
possible	NULL
roles	NULL
in	NULL
promoter	NULL
switching	NULL
,	NULL
an	NULL
infection	NULL
time	NULL
course	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
employing	NULL
the	NULL
nonimmortalizing	NULL
clone-13	NULL
strain	NULL
of	NULL
EBV	NULL
(	NULL
a	NULL
subclone	NULL
of	NULL
the	NULL
mutant	NULL
P3HR-1	NULL
strain	NULL
)	NULL
(	NULL
16	NULL
)	NULL
.	NULL

This	NULL
virus	NULL
contains	NULL
a	NULL
deletion	NULL
that	NULL
removes	NULL
the	NULL
entire	NULL
EBNA	NULL
2	NULL
gene	NULL
and	NULL
the	NULL
exons	NULL
encoding	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
EBNA	NULL
4	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Infection	NULL
of	NULL
adult	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
with	NULL
clone-13	NULL
virus	NULL
led	NULL
to	NULL
detectable	NULL
Wp	NULL
activity	NULL
within	NULL
24	NULL
hr	NULL
postinfection	NULL
,	NULL
which	NULL
remained	NULL
constant	NULL
over	NULL
the	NULL
first	NULL
6	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
Cp	NULL
activity	NULL
over	NULL
the	NULL
same	NULL
time	NULL
range	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
infection	NULL
of	NULL
adult	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
with	NULL
the	NULL
immortalizing	NULL
Akata	NULL
strain	NULL
of	NULL
EBV	NULL
led	NULL
to	NULL
detectable	NULL
Cp	NULL
activity	NULL
by	NULL
48	NULL
hr	NULL
postinfection	NULL
,	NULL
and	NULL
a	NULL
pronounced	NULL
down-regulation	NULL
of	NULL
Wp	NULL
activity	NULL
was	NULL
observed	NULL
by	NULL
96	NULL
hr	NULL
postinfection	NULL
with	NULL
a	NULL
concomitant	NULL
rise	NULL
in	NULL
Cp	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Clone-13	NULL
Virus	NULL
Contains	NULL
a	NULL
Functional	NULL
Cp	NULL
.	NULL

Since	NULL
the	NULL
clone-13	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
from	NULL
which	NULL
clone-13	NULL
virus	NULL
was	NULL
induced	NULL
)	NULL
utilizes	NULL
Wp	NULL
exclusively	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
failure	NULL
of	NULL
clone-13	NULL
virus	NULL
to	NULL
switch	NULL
to	NULL
Cp	NULL
usage	NULL
upon	NULL
infection	NULL
of	NULL
primary	NULL
B	NULL
lymphocytes	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
nonfunctional	NULL
Cp	NULL
in	NULL
this	NULL
strain	NULL
of	NULL
EBV	NULL
.	NULL

To	NULL
directly	NULL
determine	NULL
whether	NULL
Cp	NULL
is	NULL
functional	NULL
in	NULL
the	NULL
clone-13	NULL
genome	NULL
,	NULL
a	NULL
5.8-kb	NULL
region	NULL
of	NULL
the	NULL
genome	NULL
containing	NULL
Cp	NULL
was	NULL
cloned	NULL
(	NULL
from	NULL
the	NULL
EcoRI	NULL
site	NULL
at	NULL
7316	NULL
bp	NULL
to	NULL
the	NULL
Xho	NULL
I	NULL
site	NULL
at	NULL
13,143	NULL
bp	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
same	NULL
region	NULL
was	NULL
also	NULL
cloned	NULL
from	NULL
the	NULL
Cp-using	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
JY	NULL
(	NULL
18	NULL
)	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
clone-13	NULL
and	NULL
JY	NULL
fragments	NULL
were	NULL
cloned	NULL
into	NULL
a	NULL
reporter	NULL
construct	NULL
(	NULL
CWW1iglobin	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
for	NULL
structure	NULL
)	NULL
in	NULL
place	NULL
of	NULL
the	NULL
cloned	NULL
fragment	NULL
isolated	NULL
from	NULL
the	NULL
B95.8	NULL
cell	NULL
line	NULL
(	NULL
5	NULL
,	NULL
19	NULL
)	NULL
.	NULL

These	NULL
reporter	NULL
plasmids	NULL
were	NULL
introduced	NULL
back	NULL
into	NULL
the	NULL
clone-13	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
DG75	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
Cp	NULL
activity	NULL
was	NULL
assessed	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cell	NULL
lines	NULL
,	NULL
no	NULL
difference	NULL
in	NULL
Cp	NULL
activity	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
B95.8	NULL
,	NULL
JY	NULL
,	NULL
and	NULL
clone-13	NULL
reporter	NULL
plasmids	NULL
.	NULL

Thus	NULL
,	NULL
Cp	NULL
from	NULL
any	NULL
of	NULL
these	NULL
viral	NULL
strains	NULL
introduced	NULL
into	NULL
the	NULL
CWWiglobin	NULL
reporter	NULL
construct	NULL
functions	NULL
normally	NULL
in	NULL
cycling	NULL
B	NULL
lymphocytes	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
in	NULL
both	NULL
clone-13	NULL
and	NULL
DG75	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
Cp	NULL
activity	NULL
from	NULL
the	NULL
endogenous	NULL
virus	NULL
in	NULL
the	NULL
clone-13	NULL
cell	NULL
line	NULL
is	NULL
therefore	NULL
not	NULL
the	NULL
result	NULL
of	NULL
a	NULL
nonfunctional	NULL
Akata	NULL
virus	NULL
24hr	NULL
48hr	NULL
_	NULL
96hr	NULL
C1-mock	NULL
inf	NULL
28hr	NULL
6	NULL
3	NULL
©	NULL
S	NULL
WOW1	NULL
3	NULL
9	NULL
~	NULL
s	NULL
0	NULL
o	NULL
input	NULL
probe	NULL
€	NULL
#	NULL
t	NULL
protected	NULL
|	NULL
«	NULL
k	NULL
’	NULL
%	NULL
fragments	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Cl-13	NULL
virus	NULL
wowi	NULL
_	NULL
C1	NULL
144hr	NULL
‘	NULL
WOW1	NULL
probe	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
3943	NULL
Cp	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
failure	NULL
to	NULL
switch	NULL
from	NULL
Wp	NULL
to	NULL
Cp	NULL
usage	NULL
in	NULL
primary	NULL
cells	NULL
infected	NULL
with	NULL
clone-13	NULL
virus	NULL
is	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
one	NULL
or	NULL
more	NULL
of	NULL
the	NULL
EBNAs	NULL
.	NULL

A	NULL
Region	NULL
Essential	NULL
for	NULL
Cp	NULL
Activity	NULL
Functions	NULL
as	NULL
an	NULL
Enhancer	NULL
in	NULL
EBNA	NULL
2-Positive	NULL
Cell	NULL
Lines	NULL
but	NULL
Not	NULL
in	NULL
the	NULL
EBNA	NULL
2-Negative	NULL
Clone-13	NULL
Cell	NULL
Line	NULL
or	NULL
in	NULL
EBV-Negative	NULL
Cell	NULL
Lines	NULL
.	NULL

To	NULL
initially	NULL
map	NULL
cis-acting	NULL
elements	NULL
involved	NULL
in	NULL
regulating	NULL
Cp	NULL
activity	NULL
,	NULL
several	NULL
deletions	NULL
in	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
Cp	NULL
were	NULL
gener-ated	NULL
.	NULL

These	NULL
deletion	NULL
constructs	NULL
were	NULL
assayed	NULL
in	NULL
the	NULL
EBV-positive	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
lines	NULL
Jijoye	NULL
(	NULL
which	NULL
expresses	NULL
EBNA	NULL
2	NULL
and	NULL
is	NULL
the	NULL
parent	NULL
of	NULL
P3HR-1	NULL
and	NULL
clone-13	NULL
)	NULL
(	NULL
21	NULL
)	NULL
and	NULL
clone-13	NULL
and	NULL
in	NULL
the	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
DG75	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
a	NULL
1.2-kb	NULL
region	NULL
(	NULL
-2199	NULL
to	NULL
-1021	NULL
bp	NULL
upstream	NULL
of	NULL
Cp	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
Cp	NULL
activity	NULL
in	NULL
any	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
assayed	NULL
(	NULL
see	NULL
construct	NULL
d1	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
a	NULL
776-bp	NULL
region	NULL
from	NULL
-1021	NULL
to	NULL
-245	NULL
bp	NULL
abrogated	NULL
Cp	NULL
activity	NULL
almost	NULL
entirely	NULL
(	NULL
see	NULL
construct	NULL
d2	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
smaller	NULL
deletion	NULL
from	NULL
-429	NULL
to	NULL
-245	NULL
bp	NULL
also	NULL
had	NULL
the	NULL
same	NULL
effect	NULL
,	NULL
mapping	NULL
essential	NULL
sequences	NULL
to	NULL
a	NULL
184-bp	NULL
region	NULL
(	NULL
see	NULL
construct	NULL
d6	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
sequences	NULL
from	NULL
-1021	NULL
to	NULL
-429	NULL
bp	NULL
(	NULL
see	NULL
construct	NULL
d5	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
Cp	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
essential	NULL
cis-acting	NULL
elements	NULL
map	NULL
entirely	NULL
within	NULL
the	NULL
region	NULL
from	NULL
-429	NULL
to	NULL
-245	NULL
bp	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
region	NULL
functions	NULL
as	NULL
an	NULL
enhancer	NULL
,	NULL
it	NULL
was	NULL
cloned	NULL
in	NULL
both	NULL
orientations	NULL
upstream	NULL
of	NULL
the	NULL
enhancerless	NULL
SV40	NULL
early	NULL
promoter	NULL
and	NULL
transfected	NULL
into	NULL
various	NULL
cell	NULL
lines	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
EBNA	NULL
2-positive	NULL
Jijoye	NULL
cell	NULL
line	NULL
,	NULL
the	NULL
region	NULL
from	NULL
-429	NULL
to	NULL
-245	NULL
bp	NULL
exhibited	NULL
enhancer	NULL
activity	NULL
in	NULL
both	NULL
orientations	NULL
(	NULL
see	NULL
experiments	NULL
1-3	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
EBNA	NULL
2-negative	NULL
cell	NULL
line	NULL
clone-13	NULL
,	NULL
this	NULL
region	NULL
did	NULL
not	NULL
function	NULL
as	NULL
an	NULL
enhancer	NULL
,	NULL
but	NULL
rather	NULL
it	NULL
significantly	NULL
suppressed	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
the	NULL
EBV-negative	NULL
cell	NULL
line	NULL
DG75	NULL
,	NULL
this	NULL
region	NULL
also	NULL
did	NULL
not	NULL
exhibit	NULL
enhancer	NULL
activity	NULL
.	NULL

EBNA	NULL
2	NULL
Is	NULL
Required	NULL
for	NULL
Enhancer	NULL
Activity	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
EBNA	NULL
2	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
enhancer	NULL
func-tion	NULL
,	NULL
several	NULL
cell	NULL
lines	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
appropriate	NULL
reporter	NULL
construct	NULL
and	NULL
either	NULL
a	NULL
control	NULL
plasmid	NULL
or	NULL
an	NULL
EBNA	NULL
2	NULL
expression	NULL
plasmid	NULL
.	NULL

In	NULL
DG75	NULL
cells	NULL
the	NULL
region	NULL
from	NULL
-429	NULL
to	NULL
-245	NULL
,	NULL
cloned	NULL
either	NULL
upstream	NULL
or	NULL
downstream	NULL
of	NULL
a	NULL
C	NULL
DGT75	NULL
cells	NULL
Cl-13	NULL
cells	NULL
e	NULL
(	NULL
C1	NULL
probe	NULL
)	NULL
a	NULL
5	NULL
&	NULL
a	NULL
a	NULL
a	NULL
a	NULL
o	NULL
o	NULL
$	NULL
8	NULL
il	NULL
As	NULL
>	NULL
€	NULL
8	NULL
5	NULL
o	NULL
B	NULL
3	NULL
-P	NULL
-P	NULL
3	NULL
6	NULL
&	NULL
&	NULL
0	NULL
s	NULL
0	NULL
s	NULL
I	NULL
I	NULL
I	NULL
I	NULL
protected	NULL
``	NULL
&	NULL
dh	NULL
.	NULL

*	NULL
Q	NULL
#	NULL
fragments	NULL
ils	NULL
protected	NULL
e	NULL
iet	NULL
fragments	NULL
*	NULL
Infection	NULL
time	NULL
course	NULL
of	NULL
adult	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
infected	NULL
with	NULL
either	NULL
Akata	NULL
virus	NULL
(	NULL
4	NULL
)	NULL
or	NULL
clone-13	NULL
(	NULL
Cl-13	NULL
)	NULL
virus	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
cells	NULL
harvested	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
postinfection	NULL
,	NULL
hybridized	NULL
to	NULL
C1	NULL
exon-specific	NULL
and	NULL
WO/W1	NULL
splice-junction-specific	NULL
oligonucleotides	NULL
,	NULL
followed	NULL
by	NULL
digestion	NULL
with	NULL
S1	NULL
nuclease	NULL
to	NULL
determine	NULL
Cp	NULL
and	NULL
Wp	NULL
activities	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Analysis	NULL
of	NULL
Cp	NULL
activity	NULL
of	NULL
exogenous	NULL
constructs	NULL
transfected	NULL
into	NULL
either	NULL
the	NULL
clone-13	NULL
or	NULL
DG75	NULL
cell	NULL
line	NULL
.	NULL

RNA	NULL
was	NULL
harvested	NULL
72	NULL
hr	NULL
posttransfection	NULL
and	NULL
hybridized	NULL
to	NULL
C1	NULL
exon-specific	NULL
and	NULL
WO/W1	NULL
splice-junction-specific	NULL
oligonucleotides	NULL
(	NULL
5	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
digestion	NULL
with	NULL
S1	NULL
nuclease	NULL
.	NULL

The	NULL
resulting	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
10	NULL
%	NULL
urea/acrylamide	NULL
gel	NULL
.	NULL

Cp	NULL
(	NULL
B95.8	NULL
)	NULL
,	NULL
CW	NULL
Wiglobin	NULL
reporter	NULL
construct	NULL
containing	NULL
viral	NULL
BamHI	NULL
C	NULL
sequences	NULL
cloned	NULL
from	NULL
the	NULL
B95.8	NULL
marmoset	NULL
cell	NULL
line	NULL
;	NULL
Cp	NULL
(	NULL
JY	NULL
)	NULL
,	NULL
CWWiglobin	NULL
reporter	NULL
construct	NULL
containing	NULL
viral	NULL
BamHI	NULL
C	NULL
sequences	NULL
cloned	NULL
from	NULL
the	NULL
JY	NULL
cell	NULL
line	NULL
;	NULL
Cp	NULL
(	NULL
Cl-13	NULL
)	NULL
,	NULL
CWWiglobin	NULL
reporter	NULL
construct	NULL
containing	NULL
viral	NULL
BamHI	NULL
C	NULL
sequences	NULL
cloned	NULL
from	NULL
the	NULL
clone-13	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
CWW1iglobin	NULL
reporter	NULL
construct	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

3944	NULL
Biochemistry	NULL
:	NULL
Woisetschlaeger	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
JIJOYE	NULL
CLONE-13	NULL
DG75	NULL
s	NULL
5	NULL
S8	NULL
S	NULL
t	NULL
5	NULL
8	NULL
$	NULL
&	NULL
|	NULL
|	NULL
|	NULL
I	NULL
I	NULL
input	NULL
W	NULL
©	NULL
LQ	NULL
*	NULL
p	NULL
protected	NULL
|	NULL
$	NULL
@	NULL
&	NULL
&	NULL
«	NULL
s	NULL
fragments	NULL
|_	NULL
«	NULL
ume	NULL
FiG	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Analysis	NULL
of	NULL
Cp	NULL
activity	NULL
in	NULL
several	NULL
deletion	NULL
constructs	NULL
.	NULL

The	NULL
W	NULL
NA	NULL
Jijoye	NULL
,	NULL
clone-13	NULL
,	NULL
and	NULL
DG75	NULL
cell	NULL
Cp	NULL
3	NULL
Wp	NULL
3	NULL
lines	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
in-ont	NULL
.	NULL

_..	NULL
p-	NULL
&	NULL
l	NULL
o	NULL
dicated	NULL
reporter	NULL
constructs	NULL
;	NULL
RNA	NULL
errant	NULL
cles	NULL
-~	NULL
``	NULL
wo	NULL
wo	NULL
R	NULL
i	NULL
va	NULL
was	NULL
prepared	NULL
72	NULL
hr	NULL
posttransfec-Exons	NULL
icle	NULL
wil	NULL
``	NULL
vo	NULL
tion	NULL
and	NULL
analyzed	NULL
by	NULL
$	NULL
1	NULL
nuclease	NULL
4018	NULL
+1	NULL
Po	NULL
protection	NULL
employing	NULL
a	NULL
C1	NULL
exon-erea	NULL
an	NULL
“	NULL
4	NULL
Globin	NULL
__	NULL
wt	NULL
-	NULL
specific	NULL
probe	NULL
.	NULL

The	NULL
resulting	NULL
prod-else	NULL
102	NULL
!	NULL

A	NULL
o	NULL
!	NULL

Globm	NULL
-	NULL
g	NULL
,	NULL
-	NULL
ucts	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
10	NULL
%	NULL
urea/	NULL
~	NULL
aan	NULL
get	NULL
~~	NULL
!	NULL

ome	NULL
Tg	NULL
~ALSS27	NULL
``	NULL
_	NULL
_	NULL
acrylamide	NULL
gel	NULL
.	NULL

To	NULL
distinguish	NULL
be	NULL
--	NULL
--	NULL
Globin	NULL
_	NULL
d2	NULL
_	NULL
tween	NULL
endogenous	NULL
and	NULL
exogenous	NULL
429	NULL
-245	NULL
pa-	NULL
Cp	NULL
activity	NULL
in	NULL
the	NULL
Jijoye	NULL
cell	NULL
line	NULL
,	NULL
aas	NULL
a	NULL
{	NULL
Globin	NULL
_	NULL
d6	NULL
-	NULL
the	NULL
C1	NULL
exon	NULL
of	NULL
the	NULL
plasmid	NULL
was	NULL
tagged	NULL
by	NULL
site-directed	NULL
mutagene-	NULL
CAT	NULL
reporter	NULL
construct	NULL
containing	NULL
the	NULL
enhancerless	NULL
SV40	NULL
early	NULL
promoter	NULL
,	NULL
exhibited	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
activity	NULL
(	NULL
see	NULL
experiments	NULL
6-8	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
sequences	NULL
from	NULL
-429	NULL
to	NULL
-340	NULL
bp	NULL
eliminated	NULL
virtually	NULL
all	NULL
of	NULL
the	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
activity	NULL
(	NULL
see	NULL
experiments	NULL
6	NULL
and	NULL
9	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

EBNA	NULL
2-dependent	NULL
enhancer	NULL
activity	NULL
was	NULL
further	NULL
substantiated	NULL
by	NULL
employing	NULL
reporter	NULL
constructs	NULL
in	NULL
which	NULL
the	NULL
region	NULL
from	NULL
-429	NULL
to	NULL
-245	NULL
bp	NULL
was	NULL
in	NULL
its	NULL
physiological	NULL
setting	NULL
upstream	NULL
of	NULL
Cp	NULL
and	NULL
the	NULL
CAT	NULL
gene	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
C1	NULL
exon	NULL
(	NULL
C1ICAT	NULL
constructs	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cell	NULL
lines	NULL
examined	NULL
,	NULL
cotransfection	NULL
of	NULL
the	NULL
EBNA	NULL
2	NULL
expression	NULL
vector	NULL
with	NULL
the	NULL
-820/C1CAT	NULL
and	NULL
-559/C1CAT	NULL
constructs	NULL
resulted	NULL
in	NULL
increased	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
no	NULL
apparent	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
activity	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
-245/C1CAT	NULL
plasmid	NULL
.	NULL

The	NULL
EBNA	NULL
2	NULL
Enhancer	NULL
Region	NULL
Is	NULL
Essential	NULL
for	NULL
Cp	NULL
Activity	NULL
in	NULL
EBNA	NULL
2-Negative	NULL
Burkitt	NULL
Lymphoma	NULL
Cell	NULL
Lines	NULL
in	NULL
the	NULL
Presence	NULL
of	NULL
Upstream	NULL
and	NULL
Downstream	NULL
Sequences	NULL
but	NULL
in	NULL
This	NULL
Context	NULL
Is	NULL
Not	NULL
Responsive	NULL
to	NULL
EBNA	NULL
2	NULL
.	NULL

As	NULL
already	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

-	NULL
Relative	NULL
activities	NULL
of	NULL
various	NULL
CAT	NULL
reporter	NULL
constructs	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
EBNA	NULL
2	NULL
Expression	NULL
Relative	NULL
activity	NULL
Exp	NULL
.	NULL

-	NULL
Reporter	NULL
construct	NULL
plasmid	NULL
-	NULL
DG75	NULL
Clone-13	NULL
Jijoye	NULL
SVpCAT	NULL
Control	NULL
(	NULL
1.0	NULL
)	NULL
_	NULL
(	NULL
1.0	NULL
)	NULL
_	NULL
(	NULL
1.0	NULL
)	NULL
[	NULL
-429/-245	NULL
]	NULL
SVpCAT	NULL
Control	NULL
0.8	NULL
0.4	NULL
5.5	NULL
[	NULL
-245/-429	NULL
]	NULL
SVpCAT	NULL
Control	NULL
0.7	NULL
0.2	NULL
4.3	NULL
SVpCAT	NULL
[	NULL
-429/-245	NULL
]	NULL
Control	NULL
0.6	NULL
-	NULL
SVpCAT	NULL
(	NULL
[	NULL
-340/-245	NULL
}	NULL
Control	NULL
1.2	NULL
-	NULL
SVpCAT	NULL
EBNA	NULL
2	NULL
1.7	NULL
-	NULL
[	NULL
-429/-245	NULL
]	NULL
SVpCAT	NULL
EBNA	NULL
2	NULL
13.4	NULL
-	NULL
SVpCAT	NULL
[	NULL
-429/-245	NULL
]	NULL
)	NULL
EBNA	NULL
2	NULL
6.4	NULL
-	NULL
SVpCAT	NULL
[	NULL
-340/-245	NULL
}	NULL
EBNA	NULL
2	NULL
2.1	NULL
-	NULL
10	NULL
-	NULL
-820/C1CAT	NULL
Control	NULL
(	NULL
1.0	NULL
)	NULL
(	NULL
1.0	NULL
)	NULL
(	NULL
1.0	NULL
)	NULL
w	NULL
c	NULL
J	NULL
O	NULL
ta	NULL
k	NULL
w	NULL
N	NULL
o	NULL
11	NULL
-559/CICAT	NULL
Control	NULL
1.0	NULL
2.2	NULL
0.7	NULL
12	NULL
-245/C1CAT	NULL
Control	NULL
0.7	NULL
5.4	NULL
0.1	NULL
13	NULL
CWY2CAT	NULL
Control	NULL
0.6	NULL
-	NULL
14	NULL
-	NULL
-820/C1CAT	NULL
15	NULL
-S559/CICAT	NULL
16	NULL
-245/C1ICAT	NULL
17	NULL
-	NULL
CWY2CAT	NULL
-	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

EBNA	NULL
2	NULL
5.8	NULL
3.6	NULL
2.5	NULL
EBNA	NULL
2	NULL
9.6	NULL
5.1	NULL
1.4	NULL
EBNA	NULL
2	NULL
0.7	NULL
3.2	NULL
0.1	NULL
EBNA	NULL
2	NULL
1.0	NULL
-	NULL
r~~	NULL
{	NULL
Globin	NULL
d5	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
region	NULL
from	NULL
-429	NULL
to	NULL
-245	NULL
bp	NULL
upstream	NULL
of	NULL
Cp	NULL
is	NULL
essential	NULL
for	NULL
Cp	NULL
activity	NULL
in	NULL
both	NULL
EBNA	NULL
2-positive	NULL
and	NULL
EBNA	NULL
2-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
lines	NULL
in	NULL
the	NULL
context	NULL
of	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
.	NULL

However	NULL
,	NULL
when	NULL
C1CAT	NULL
constructs	NULL
containing	NULL
limited	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
were	NULL
assayed	NULL
,	NULL
deletion	NULL
of	NULL
this	NULL
region	NULL
(	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
EBNA	NULL
2	NULL
expression	NULL
vector	NULL
)	NULL
reduced	NULL
activity	NULL
only	NULL
in	NULL
the	NULL
EBNA	NULL
2-positive	NULL
cell	NULL
line	NULL
Jijoye	NULL
(	NULL
see	NULL
experiments	NULL
11	NULL
and	NULL
12	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
deletion	NULL
of	NULL
these	NULL
sequences	NULL
resulted	NULL
in	NULL
increased	NULL
activity	NULL
in	NULL
the	NULL
clone-13	NULL
cell	NULL
line	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
these	NULL
sequences	NULL
act	NULL
as	NULL
a	NULL
suppressor	NULL
in	NULL
clone-13	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EBNA	NULL
2	NULL
(	NULL
compare	NULL
experiments	NULL
1	NULL
and	NULL
2	NULL
and	NULL
also	NULL
11	NULL
and	NULL
12	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
,	NULL
however	NULL
,	NULL
that	NULL
with	NULL
the	NULL
short	NULL
C1CAT	NULL
constructs	NULL
the	NULL
observed	NULL
activity	NULL
did	NULL
not	NULL
originate	NULL
from	NULL
Cp	NULL
but	NULL
rather	NULL
from	NULL
promoters	NULL
associated	NULL
with	NULL
the	NULL
plasmid	NULL
.	NULL

To	NULL
directly	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
transcription	NULL
initiating	NULL
from	NULL
Cp	NULL
was	NULL
assessed	NULL
by	NULL
employing	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
system	NULL
with	NULL
clone-13	NULL
and	NULL
DG75	NULL
whole-cell	NULL
extracts	NULL
.	NULL

With	NULL
both	NULL
extracts	NULL
,	NULL
the	NULL
initial	NULL
observation	NULL
that	NULL
the	NULL
region	NULL
from	NULL
-429	NULL
to	NULL
-245	NULL
bp	NULL
is	NULL
essential	NULL
for	NULL
Cp	NULL
activity	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
(	NULL
CW	NULL
Wiglobin	NULL
and	NULL
CWW1d6globin	NULL
)	NULL
,	NULL
was	NULL
reproduced	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
system	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
comparison	NULL
of	NULL
Cp	NULL
activity	NULL
exhibited	NULL
by	NULL
either	NULL
-820/C1CAT	NULL
or	NULL
-559/C1CAT	NULL
and	NULL
-245/C1CAT	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
system	NULL
revealed	NULL
that	NULL
the	NULL
-559	NULL
to	NULL
-245	NULL
bp	NULL
sequence	NULL
is	NULL
not	NULL
required	NULL
for	NULL
Cp	NULL
activity	NULL
in	NULL
these	NULL
constructs	NULL
.	NULL

Extending	NULL
the	NULL
upstream	NULL
region	NULL
to	NULL
include	NULL
oriP	NULL
did	NULL
not	NULL
significantly	NULL
alter	NULL
the	NULL
dependence	NULL
of	NULL
Cp	NULL
activity	NULL
on	NULL
the	NULL
d6	NULL
(	NULL
-429	NULL
to	NULL
-245	NULL
bp	NULL
)	NULL
region	NULL
(	NULL
see	NULL
oriP/C1	NULL
vs.	NULL
oriP/C1d6	NULL
,	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
sequences	NULL
from	NULL
-534	NULL
to	NULL
-245	NULL
bp	NULL
did	NULL
appreciably	NULL
diminish	NULL
Cp	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
extensive	NULL
downstream	NULL
sequences	NULL
(	NULL
see	NULL
-534/CWW1I	NULL
vs.	NULL
-245/	NULL
CWW1	NULL
,	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
although	NULL
this	NULL
effect	NULL
was	NULL
small	NULL
compared	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
deleting	NULL
these	NULL
sequences	NULL
in	NULL
the	NULL
context	NULL
of	NULL
both	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
(	NULL
see	NULL
CWW1	NULL
vs.	NULL
CWW1d6	NULL
,	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
region	NULL
is	NULL
essential	NULL
for	NULL
Cp	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
extensive	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
,	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EBNA	NULL
2	NULL
,	NULL
it	NULL
was	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
EBNA	NULL
2	NULL
expression	NULL
influenced	NULL
Cp	NULL
activity	NULL
in	NULL
this	NULL
setting	NULL
.	NULL

Cotransfection	NULL
of	NULL
DG75	NULL
sis	NULL
as	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

wt	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

Biochemistry	NULL
:	NULL
Woisetschlaeger	NULL
et	NULL
al	NULL
.	NULL

DG75	NULL
_	NULL
Clone-13	NULL
o	NULL
t	NULL
A	NULL
&	NULL
n	NULL
Clone-13	NULL
|	NULL
]	NULL
d6	NULL
d6	NULL
5	NULL
5	NULL
S	NULL
S	NULL
&	NULL
&	NULL
oriP/C1d6	NULL
245/C	NULL
C	NULL
C	NULL
C	NULL
9/C	NULL
C	NULL
CWW1	NULL
CwWi	NULL
245/01	NULL
-	NULL
CWW1	NULL
-	NULL
-245/CWW1	NULL
-	NULL
-s34/Cwwi	NULL
--	NULL
245/CWW1	NULL
-	NULL
-534/CWW1	NULL
-	NULL
oriP/C1	NULL
-	NULL
CWW1d6	NULL
5	NULL
5	NULL
5	NULL
5	NULL
3	NULL
$	NULL
8	NULL
§	NULL
1	NULL
d	NULL
C	NULL
W	NULL
Ww	NULL
oriP	NULL
vp	NULL
§	NULL
bag	NULL
5	NULL
Wp	NULL
``	NULL
I-	NULL
l	NULL
It	NULL
1	NULL
[	NULL
Exons	NULL
C1C2	NULL
wo	NULL
wa	NULL
wo	NULL
we	NULL
o18	NULL
+1	NULL
wi	NULL
wi	NULL
i=	NULL
a=	NULL
429	NULL
245	NULL
Globin	NULL
CWW1	NULL
ery	NULL
CWWids	NULL
Be	NULL
--	NULL
a	NULL
_	NULL
--	NULL
-	NULL
csegiowmi	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
{	NULL
[	NULL
GAT	NULL
oririci	NULL
**	NULL
``	NULL
‘	NULL
i	NULL
oriP/C1d6	NULL
_§	NULL
‘	NULL
:	NULL
-559/C1	NULL
-245/C1	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Influence	NULL
of	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
on	NULL
the	NULL
dependence	NULL
of	NULL
Cp	NULL
on	NULL
the	NULL
EBNA	NULL
2	NULL
enhancer	NULL
region	NULL
.	NULL

The	NULL
indicated	NULL
reporter	NULL
constructs	NULL
were	NULL
assayed	NULL
by	NULL
employing	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
system	NULL
with	NULL
either	NULL
DG75	NULL
or	NULL
clone-13	NULL
whole-cell	NULL
extracts	NULL
.	NULL

RNA	NULL
was	NULL
recovered	NULL
from	NULL
the	NULL
reactions	NULL
,	NULL
hybridized	NULL
with	NULL
a	NULL
C1	NULL
exon-specific	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
and	NULL
digested	NULL
with	NULL
S1	NULL
nuclease	NULL
.	NULL

The	NULL
resulting	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
10	NULL
%	NULL
urea/acrylamide	NULL
gel	NULL
.	NULL

The	NULL
filled	NULL
arrowhead	NULL
indicates	NULL
total	NULL
protection	NULL
of	NULL
the	NULL
input	NULL
probe	NULL
,	NULL
presumably	NULL
resulting	NULL
from	NULL
transcription	NULL
initiating	NULL
upstream	NULL
of	NULL
Cp	NULL
.	NULL

The	NULL
open	NULL
arrowhead	NULL
indicates	NULL
specific	NULL
protection	NULL
of	NULL
transcripts	NULL
initiating	NULL
from	NULL
Cp	NULL
.	NULL

cells	NULL
with	NULL
CWY2CAT	NULL
(	NULL
see	NULL
wt	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
for	NULL
structure	NULL
)	NULL
and	NULL
either	NULL
a	NULL
control	NULL
plasmid	NULL
or	NULL
an	NULL
EBNA	NULL
2	NULL
expression	NULL
vector	NULL
revealed	NULL
that	NULL
there	NULL
was	NULL
little	NULL
transactivation	NULL
by	NULL
EBNA	NULL
2	NULL
(	NULL
experiments	NULL
13	NULL
and	NULL
17	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
was	NULL
confirmed	NULL
by	NULL
S1	NULL
nuclease	NULL
protection	NULL
monitoring	NULL
transcription	NULL
initiating	NULL
from	NULL
Cp	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
elements	NULL
within	NULL
the	NULL
EBNA	NULL
2	NULL
enhancer	NULL
interact	NULL
with	NULL
distal	NULL
elements	NULL
and	NULL
that	NULL
these	NULL
interactions	NULL
preclude	NULL
further	NULL
enhancement	NULL
by	NULL
EBNA	NULL
2	NULL
.	NULL

B	NULL
Lymphocyte-Specific	NULL
Transcription	NULL
Factor	NULL
Binding	NULL
in	NULL
the	NULL
Region	NULL
Containing	NULL
the	NULL
EBNA	NULL
2-Dependent	NULL
Enhancer	NULL
.	NULL

To	NULL
identify	NULL
regions	NULL
binding	NULL
transcription	NULL
factors	NULL
that	NULL
may	NULL
be	NULL
important	NULL
for	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
activity	NULL
,	NULL
DNase	NULL
I	NULL
protection	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
employing	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
several	NULL
lymphocyte	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

A	NULL
large	NULL
footprint	NULL
extending	NULL
from	NULL
approximately	NULL
-380	NULL
to	NULL
-330	NULL
bp	NULL
was	NULL
observed	NULL
with	NULL
all	NULL
B-lymphocyte	NULL
extracts	NULL
examined	NULL
.	NULL

Protection	NULL
of	NULL
this	NULL
region	NULL
by	NULL
extract	NULL
prepared	NULL
from	NULL
the	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
Ramos	NULL
indicates	NULL
that	NULL
it	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
EBV	NULL
antigens	NULL
.	NULL

Notably	NULL
,	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
only	NULL
protected	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
extensive	NULL
B-lymphocyte	NULL
footprint	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
clone-13	NULL
cell	NULL
line	NULL
specifically	NULL
protected	NULL
the	NULL
region	NULL
from	NULL
about	NULL
-310	NULL
to	NULL
-330	NULL
bp	NULL
.	NULL

The	NULL
latter	NULL
result	NULL
may	NULL
be	NULL
of	NULL
some	NULL
interest	NULL
since	NULL
in	NULL
clone-13	NULL
cells	NULL
the	NULL
EBNA	NULL
2	NULL
enhancer	NULL
acts	NULL
as	NULL
a	NULL
suppressor	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EBNA	NULL
2	NULL
,	NULL
an	NULL
effect	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
DG75	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
paper	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
infection	NULL
of	NULL
peripheral	NULL
B	NULL
lymphocytes	NULL
with	NULL
an	NULL
EBNA	NULL
2-negative	NULL
EBV	NULL
mutant	NULL
did	NULL
not	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
3945	NULL
result	NULL
in	NULL
a	NULL
switch	NULL
from	NULL
Wp	NULL
to	NULL
Cp	NULL
usage	NULL
.	NULL

This	NULL
failure	NULL
to	NULL
switch	NULL
from	NULL
Wp	NULL
to	NULL
Cp	NULL
usage	NULL
could	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
a	NULL
mutant	NULL
Cp	NULL
in	NULL
the	NULL
viral	NULL
genome	NULL
.	NULL

Furthermore	NULL
,	NULL
characterization	NULL
of	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
Cp	NULL
identified	NULL
a	NULL
region	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
Cp	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
and	NULL
that	NULL
contains	NULL
an	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
.	NULL

However	NULL
,	NULL
EBNA	NULL
2-responsive	NULL
enhancer	NULL
function	NULL
could	NULL
only	NULL
be	NULL
demonstrated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
extensive	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
.	NULL

Several	NULL
important	NULL
conclusions	NULL
can	NULL
be	NULL
inferred	NULL
from	NULL
this	NULL
data	NULL
:	NULL
(	NULL
?	NULL
)	NULL

since	NULL
clone-13	NULL
virus	NULL
fails	NULL
to	NULL
switch	NULL
from	NULL
Wp	NULL
to	NULL
Cp	NULL
usage	NULL
in	NULL
primary	NULL
B	NULL
lymphocytes	NULL
,	NULL
expression	NULL
of	NULL
some	NULL
of	NULL
the	NULL
EBNAs	NULL
is	NULL
required	NULL
in	NULL
these	NULL
cells	NULL
for	NULL
Wp	NULL
to	NULL
Cp	NULL
switching	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
preferential	NULL
utilization	NULL
of	NULL
Cp	NULL
over	NULL
Wp	NULL
in	NULL
all	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
lines	NULL
examined	NULL
(	NULL
both	NULL
EBNA	NULL
2-positive	NULL
and	NULL
EBNA	NULL
2-negative	NULL
)	NULL
indicates	NULL
that	NULL
in	NULL
cycling	NULL
B	NULL
lymphocytes	NULL
EBNA	NULL
2	NULL
is	NULL
not	NULL
required	NULL
for	NULL
Cp	NULL
activity	NULL
;	NULL
(	NULL
ii	NULL
?	NULL
)	NULL

the	NULL
inability	NULL
of	NULL
EBNA	NULL
2	NULL
to	NULL
enhance	NULL
Cp	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
indicates	NULL
that	NULL
elements	NULL
within	NULL
the	NULL
enhancer	NULL
are	NULL
involved	NULL
in	NULL
interactions	NULL
with	NULL
distal	NULL
elements	NULL
and	NULL
that	NULL
these	NULL
interactions	NULL
preclude	NULL
further	NULL
enhancement	NULL
by	NULL
EBNA	NULL
2	NULL
.	NULL

When	NULL
the	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
EBNA-dependent	NULL
enhancer	NULL
was	NULL
compared	NULL
to	NULL
the	NULL
EBV	NULL
BamHI	NULL
C	NULL
and	NULL
W	NULL
sequences	NULL
,	NULL
two	NULL
regions	NULL
of	NULL
striking	NULL
homology	NULL
were	NULL
identified	NULL
.	NULL

The	NULL
B-cell-specific	NULL
portion	NULL
of	NULL
the	NULL
DNase	NULL
I	NULL
footprint	NULL
contains	NULL
the	NULL
sequence	NULL
5-GAGTGCTATCTTTGGA-3	NULL
'	NULL
,	NULL
which	NULL
is	NULL
ho-mologous	NULL
to	NULL
a	NULL
region	NULL
in	NULL
oriP	NULL
at	NULL
-3927	NULL
to	NULL
-3943	NULL
bp	NULL
upstream	NULL
of	NULL
Cp	NULL
(	NULL
5-GAGTGCTATCcTTtGe-3	NULL
'	NULL
)	NULL
and	NULL
to	NULL
another	NULL
region	NULL
located	NULL
downstream	NULL
of	NULL
Cp	NULL
in	NULL
the	NULL
BamHI	NULL
W	NULL
fragment	NULL
at	NULL
position	NULL
+2829	NULL
to	NULL
+2844	NULL
bp	NULL
(	NULL
5'-tgcTGCTATCTTTaGA-3	NULL
'	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
striking	NULL
homology	NULL
common	NULL
to	NULL
these	NULL
three	NULL
sequences	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
they	NULL
bind	NULL
the	NULL
same	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
which	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
a	NULL
three-component	NULL
interaction	NULL
between	NULL
the	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
and	NULL
distal	NULL
elements	NULL
,	NULL
thus	NULL
forming	NULL
a	NULL
tripartite	NULL
regulatory	NULL
structure	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
Cp	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
Cp	NULL
can	NULL
not	NULL
be	NULL
transactivated	NULL
by	NULL
EBNA	NULL
2	NULL
in	NULL
reporter	NULL
constructs	NULL
containing	NULL
extensive	NULL
upstream	NULL
and	NULL
downstream	NULL
sequences	NULL
raises	NULL
the	NULL
question	NULL
of	NULL
the	NULL
significance	NULL
of	NULL
the	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
and	NULL
the	NULL
role	NULL
of	NULL
EBNA	NULL
2	NULL
,	NULL
if	NULL
any	NULL
,	NULL
in	NULL
promoter	NULL
switching	NULL
.	NULL

This	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
relates	NULL
to	NULL
the	NULL
more	NULL
fundamental	NULL
question	NULL
of	NULL
the	NULL
respective	NULL
roles	NULL
of	NULL
Wp	NULL
and	NULL
Cp	NULL
.	NULL

There	NULL
are	NULL
three	NULL
obvious	NULL
differences	NULL
between	NULL
Wp	NULL
and	NULL
Cp	NULL
.	NULL

First	NULL
,	NULL
there	NULL
are	NULL
multiple	NULL
copies	NULL
of	NULL
Wp	NULL
,	NULL
which	NULL
may	NULL
be	NULL
important	NULL
for	NULL
generating	NULL
sufficient	NULL
transcription	NULL
of	NULL
EBNA	NULL
4	NULL
and	NULL
EBNA	NULL
2	NULL
during	NULL
the	NULL
initial	NULL
phase	NULL
of	NULL
infection	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
Cp-	NULL
and	NULL
Wp-initiated	NULL
transcripts	NULL
are	NULL
distinct	NULL
,	NULL
and	NULL
this	NULL
may	NULL
influence	NULL
the	NULL
splicing	NULL
of	NULL
the	NULL
long	NULL
primary	NULL
transcripts	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
5	NULL
'	NULL
regulatory	NULL
regions	NULL
of	NULL
Cp	NULL
and	NULL
Wp	NULL
are	NULL
different	NULL
,	NULL
and	NULL
this	NULL
may	NULL
reflect	NULL
a	NULL
need	NULL
to	NULL
run	NULL
these	NULL
promoters	NULL
in	NULL
different	NULL
activation	NULL
and	NULL
differentiation	NULL
states	NULL
of	NULL
the	NULL
infected	NULL
cells	NULL
.	NULL

While	NULL
it	NULL
appears	NULL
certain	NULL
that	NULL
EBNAs	NULL
2	NULL
and	NULL
4	NULL
are	NULL
expressed	NULL
from	NULL
Wp-initiated	NULL
transcripts	NULL
during	NULL
the	NULL
initial	NULL
phase	NULL
of	NULL
infection	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
the	NULL
other	NULL
EBNAs	NULL
are	NULL
also	NULL
expressed	NULL
from	NULL
Wp	NULL
transcripts	NULL
or	NULL
whether	NULL
switching	NULL
to	NULL
Cp	NULL
is	NULL
required	NULL
before	NULL
they	NULL
can	NULL
be	NULL
expressed	NULL
.	NULL

There	NULL
is	NULL
some	NULL
evidence	NULL
in	NULL
support	NULL
of	NULL
a	NULL
model	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
EBNAs	NULL
1	NULL
,	NULL
3a	NULL
,	NULL
3b	NULL
,	NULL
and	NULL
3¢	NULL
requires	NULL
switching	NULL
to	NULL
Cp	NULL
usage	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
infection	NULL
of	NULL
primary	NULL
B	NULL
lymphocytes	NULL
with	NULL
clone-16	NULL
virus	NULL
(	NULL
both	NULL
clone-13	NULL
and	NULL
clone-16	NULL
are	NULL
subclones	NULL
of	NULL
the	NULL
P3HR-1	NULL
cell	NULL
line	NULL
)	NULL
leads	NULL
to	NULL
expression	NULL
of	NULL
EBNA	NULL
4	NULL
but	NULL
not	NULL
EBNAs	NULL
1	NULL
,	NULL
3a	NULL
,	NULL
3b	NULL
,	NULL
or	NULL
3¢	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
no	NULL
EBNA	NULL
1	NULL
or	NULL
3	NULL
cDNA	NULL
clones	NULL
have	NULL
been	NULL
characterized	NULL
that	NULL
initiate	NULL
from	NULL
Wp	NULL
in	NULL
Wp-using	NULL
cell	NULL
lines	NULL
,	NULL
leaving	NULL
unresolved	NULL
the	NULL
question	NULL
of	NULL
their	NULL
origin	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
demonstrated	NULL
successful	NULL
immortalization	NULL
of	NULL
human	NULL
PBL	NULL
s	NULL
with	NULL
clone-13	NULL
virus	NULL
that	NULL
had	NULL
regained	NULL
a	NULL
functional	NULL
EBNA	NULL
2	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
promoter	NULL
usage	NULL
in	NULL
these	NULL
cell	NULL
cultures	NULL
revealed	NULL
Cp	NULL
usage	NULL
in	NULL
3946	NULL
Biochemistry	NULL
:	NULL
Woisetschlaeger	NULL
et	NULL
al	NULL
.	NULL

A	NULL
Cpt	NULL
)	NULL
ke	NULL
-	NULL
&	NULL
.	NULL

addition	NULL
to	NULL
some	NULL
Wp	NULL
activity	NULL
(	NULL
M.W	NULL
.	NULL

and	NULL
S.H.S	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

If	NULL
full	NULL
expression	NULL
of	NULL
all	NULL
the	NULL
EBNAs	NULL
requires	NULL
switching	NULL
from	NULL
Wp	NULL
to	NULL
Cp	NULL
usage	NULL
,	NULL
then	NULL
the	NULL
role	NULL
of	NULL
EBNA	NULL
2	NULL
and	NULL
the	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
may	NULL
be	NULL
during	NULL
a	NULL
discrete	NULL
time	NULL
period	NULL
in	NULL
the	NULL
initial	NULL
stages	NULL
of	NULL
infection	NULL
prior	NULL
to	NULL
full	NULL
transformation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

One	NULL
possible	NULL
point	NULL
of	NULL
action	NULL
for	NULL
EBNA	NULL
2	NULL
may	NULL
be	NULL
in	NULL
the	NULL
first	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
:	NULL
It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
infection	NULL
of	NULL
resting	NULL
B	NULL
lymphocytes	NULL
with	NULL
clone-13	NULL
virus	NULL
activates	NULL
the	NULL
infected	NULL
cells	NULL
to	NULL
progress	NULL
into	NULL
early	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
arrest	NULL
at	NULL
that	NULL
point	NULL
,	NULL
however	NULL
,	NULL
and	NULL
do	NULL
not	NULL
complete	NULL
a	NULL
full	NULL
round	NULL
of	NULL
the	NULL
cycle	NULL
.	NULL

Thus	NULL
,	NULL
during	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
G1	NULL
,	NULL
EBNA	NULL
2	NULL
expression	NULL
may	NULL
directly	NULL
or	NULL
indirectly	NULL
up-regulate	NULL
Cp	NULL
via	NULL
the	NULL
Cp-associated	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
.	NULL

This	NULL
in	NULL
turn	NULL
may	NULL
allow	NULL
expression	NULL
of	NULL
the	NULL
other	NULL
EBNAs	NULL
,	NULL
some	NULL
of	NULL
which	NULL
may	NULL
be	NULL
required	NULL
to	NULL
complete	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
cycling	NULL
B-cell	NULL
lines	NULL
,	NULL
EBNA	NULL
2	NULL
is	NULL
obviously	NULL
not	NULL
required	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
enhancer	NULL
but	NULL
rather	NULL
functions	NULL
in	NULL
cooperation	NULL
with	NULL
upstream	NULL
and	NULL
downstream	NULL
elements	NULL
.	NULL

Note	NULL
Added	NULL
in	NULL
Proof	NULL
.	NULL

The	NULL
EBN	NULL
A	NULL
2-dependent	NULL
enhancer	NULL
reported	NULL
here	NULL
has	NULL
also	NULL
been	NULL
recently	NULL
identified	NULL
by	NULL
Sung	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
K.	NULL
Takata	NULL
for	NULL
providing	NULL
the	NULL
Akata	NULL
cell	NULL
line	NULL
and	NULL
Dr.	NULL
L.	NULL
Rymo	NULL
for	NULL
providing	NULL
both	NULL
the	NULL
DG75	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
EBNA	NULL
2	NULL
expression	NULL
vector	NULL
.	NULL

We	NULL
would	NULL
also	NULL
like	NULL
to	NULL
thank	NULL
Dr.	NULL
E.	NULL
Flemington	NULL
for	NULL
help	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
analysis	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
Grants	NULL
CA43143	NULL
(	NULL
S.H.S	NULL
.	NULL
)	NULL

and	NULL
CA7554	NULL
(	NULL
J.L.S	NULL
.	NULL
)	NULL

from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
by	NULL
Postdoctoral	NULL
Fellowships	NULL
to	NULL
M.W	NULL
.	NULL

from	NULL
the	NULL
Fonds	NULL
zur	NULL
Foerderung	NULL
der	NULL
Wissenschaftlichen	NULL
For-schung	NULL
,	NULL
Vienna	NULL
,	NULL
and	NULL
to	NULL
X.W.J	NULL
.	NULL

from	NULL
the	NULL
Lady	NULL
Tata	NULL
Memorial	NULL
Trust	NULL
.	NULL

1	NULL
.	NULL

Klein	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Adv	NULL
.	NULL

Viral	NULL
Oncol	NULL
.	NULL

8	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
-	NULL
NO	NULL
EXTRACT	NULL
-	NULL
RAMOS/B95.8	NULL
-	NULL
NO	NULL
EXTRACT	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
of	NULL
the	NULL
region	NULL
containing	NULL
the	NULL
EBNA	NULL
2-dependent	NULL
enhancer	NULL
.	NULL

Footprinting	NULL
was	NULL
performed	NULL
with	NULL
crude	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
indicated	NULL
cell	NULL
lines	NULL
[	NULL
Ramos	NULL
,	NULL
an	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
;	NULL
Ramos/	NULL
B95.8	NULL
,	NULL
EBV-converted	NULL
Ramos	NULL
;	NULL
Jijoye	NULL
,	NULL
an	NULL
EBV-positive	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
;	NULL
clone-13	NULL
(	NULL
CH-13	NULL
)	NULL
,	NULL
an	NULL
EBV-positive	NULL
,	NULL
EBNA	NULL
2-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
;	NULL
Jurkat	NULL
,	NULL
a	NULL
T-cell	NULL
line	NULL
]	NULL
.	NULL

Protected	NULL
regions	NULL
are	NULL
bracketed	NULL
,	NULL
and	NULL
the	NULL
relative	NULL
positions	NULL
of	NULL
the	NULL
protected	NULL
regions	NULL
with	NULL
respect	NULL
to	NULL
transcription	NULL
initiation	NULL
from	NULL
Cp	NULL
are	NULL
indicated	NULL
.	NULL

NE	NULL
,	NULL
no	NULL
extract	NULL
.	NULL

Cp	NULL
(	NULL
-	NULL
)	NULL
and	NULL
Cp	NULL
(	NULL
+	NULL
)	NULL
indicate	NULL
the	NULL
non-coding	NULL
and	NULL
coding	NULL
strands	NULL
,	NULL
respectively	NULL
.	NULL

Epstein	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

&	NULL
Achong	NULL
,	NULL
B.	NULL
G.	NULL
(	NULL
1986	NULL
)	NULL
The	NULL
Epstein	NULL
Barr	NULL
Virus	NULL
:	NULL
Recent	NULL
Advances	NULL
(	NULL
Heinemann	NULL
,	NULL
London	NULL
)	NULL
.	NULL

Kieff	NULL
,	NULL
E.	NULL
&	NULL
Liebovitz	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Virology	NULL
,	NULL
eds	NULL
.	NULL

Fields	NULL
,	NULL
B.	NULL
,	NULL
Knipe	NULL
,	NULL
D.	NULL
,	NULL
Chanock	NULL
,	NULL
R.	NULL
,	NULL
Hirsh	NULL
,	NULL
M.	NULL
,	NULL
Melnick	NULL
,	NULL
J.	NULL
,	NULL
Monath	NULL
,	NULL
T.	NULL
&	NULL
Roizman	NULL
,	NULL
B	NULL
.	NULL

(	NULL
Raven	NULL
,	NULL
New	NULL
York	NULL
}	NULL
,	NULL
pp	NULL
.	NULL

1889-1920	NULL
.	NULL

Woisetschlaeger	NULL
,	NULL
M..	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
&	NULL
Speck	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
6498-6502	NULL
.	NULL

Woisetschlaeger	NULL
,	NULL
M.	NULL
,	NULL
Yandava	NULL
,	NULL
C.	NULL
N.	NULL
,	NULL
Furmanski	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
&	NULL
Speck	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
1725-1729	NULL
.	NULL

Ricksten	NULL
,	NULL
A.	NULL
,	NULL
Olsson	NULL
,	NULL
A.	NULL
,	NULL
Andersson	NULL
,	NULL
T.	NULL
&	NULL
Rymo	NULL
,	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
,	NULL
8391-8410	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
&	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
.	NULL

Ricksten	NULL
,	NULL
A.	NULL
,	NULL
Svensson	NULL
,	NULL
C..	NULL
Welinder	NULL
,	NULL
C.	NULL
&	NULL
Rymo	NULL
,	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

68	NULL
,	NULL
2407-2418	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
&	NULL
Speck	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
1217-1226	NULL
.	NULL

Takada	NULL
,	NULL
K.	NULL
&	NULL
Ono	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
445-449	NULL
.	NULL

Auffray	NULL
,	NULL
C.	NULL
&	NULL
Rougeon	NULL
,	NULL
T.	NULL
(	NULL
1980	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

107	NULL
,	NULL
303-314	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
Mitchell	NULL
,	NULL
P.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
741-752	NULL
.	NULL

Hai	NULL
,	NULL
T.	NULL
,	NULL
Horikoshi	NULL
,	NULL
M.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
&	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
1043-1051	NULL
.	NULL

Rooney	NULL
,	NULL
C.	NULL
,	NULL
Howe	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Speck	NULL
,	NULL
S.	NULL
H.	NULL
&	NULL
Miller	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
1531-1539	NULL
.	NULL

Rabson	NULL
,	NULL
M.	NULL
,	NULL
Gradoville	NULL
,	NULL
L.	NULL
,	NULL
Heston	NULL
,	NULL
L.	NULL
&	NULL
Miller	NULL
,	NULL
G.	NULL
(	NULL
1982	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

44	NULL
,	NULL
834-844	NULL
.	NULL

Jeang	NULL
,	NULL
K.	NULL
&	NULL
Hayward	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1983	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

48	NULL
,	NULL
135-148	NULL
.	NULL

Terhorst	NULL
,	NULL
C.	NULL
,	NULL
Parkham	NULL
,	NULL
P.	NULL
,	NULL
Mann	NULL
,	NULL
D.	NULL
L.	NULL
&	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1976	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
73	NULL
,	NULL
910-914	NULL
.	NULL

Skare	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1980	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77	NULL
,	NULL
3860-3864	NULL
.	NULL

Ben-Bassat	NULL
,	NULL
H.	NULL
,	NULL
Goldblum	NULL
,	NULL
N.	NULL
,	NULL
Mitrani	NULL
,	NULL
S.	NULL
,	NULL
Goldblum	NULL
,	NULL
T.	NULL
,	NULL
Yoffey	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Cohen	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Bentwich	NULL
,	NULL
Z.	NULL
,	NULL
Ramot	NULL
,	NULL
B.	NULL
,	NULL
Klein	NULL
,	NULL
E.	NULL
&	NULL
Klein	NULL
,	NULL
G.	NULL
(	NULL
1977	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
19	NULL
,	NULL
27-33	NULL
.	NULL

Brandsman	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Miller	NULL
,	NULL
G.	NULL
(	NULL
1980	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77	NULL
,	NULL
6851-6855	NULL
.	NULL

Hammerschmidt	NULL
,	NULL
W.	NULL
&	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
340	NULL
,	NULL
393-397	NULL
.	NULL

Gordon	NULL
,	NULL
J.	NULL
,	NULL
Walker	NULL
,	NULL
L.	NULL
,	NULL
Guy	NULL
,	NULL
G.	NULL
,	NULL
Brown	NULL
,	NULL
G.	NULL
,	NULL
Rowe	NULL
,	NULL
M.	NULL
&	NULL
Rickinson	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Immunology	NULL
58	NULL
,	NULL
591-598	NULL
.	NULL

Sung	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Kenney	NULL
,	NULL
S.	NULL
,	NULL
Gutsch	NULL
,	NULL
D.	NULL
&	NULL
Pagano	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

65	NULL
,	NULL
2164-2169	NULL
.	NULL

